| Literature DB >> 35239984 |
Alisha Duetschler1,2, Grzegorz Bauman3,4, Oliver Bieri3,4, Philippe C Cattin3,5, Stefanie Ehrbar6,7, Georg Engin-Deniz1,2, Alina Giger3,5, Mirjana Josipovic8, Christoph Jud3,5, Miriam Krieger1,2, Damien Nguyen3,4, Gitte F Persson8,9,10, Rares Salomir11,12, Damien C Weber1,6,13, Antony J Lomax1,2, Ye Zhang1.
Abstract
PURPOSE: Respiratory motion is one of the major challenges in radiotherapy. In this work, a comprehensive and clinically plausible set of 4D numerical phantoms, together with their corresponding "ground truths," have been developed and validated for 4D radiotherapy applications.Entities:
Keywords: 4D imaging; 4D numerical phantom; 4DMRI; intrafraction motion; proton therapy
Mesh:
Substances:
Year: 2022 PMID: 35239984 PMCID: PMC9313613 DOI: 10.1002/mp.15591
Source DB: PubMed Journal: Med Phys ISSN: 0094-2405 Impact factor: 4.506
FIGURE 1(a) Top: CT geometries from 13 patients. CT1–CT6 are end exhale (EE) reference CTs extracted from 4DCTs, whereas CT7–CT13 were acquired during deep‐inspiration breath‐hold (DIBH). Bottom: MRI lung geometries from five volunteers at EE reference phases from the 4DMRIs. (b) Volumes of both lung halves for CTs and MRIs. For the 4DMRIs the volumes for both the EE and the end inhalation (EI) reference state are shown
FIGURE 2Workflow to generate a 4DCT(MRI) based on a reference CT and a 4DMRI
FIGURE 3For each of the 4DMRI geometries, a point in the dome of each half of the lung was selected (see (a) for MRI1) and the superior–inferior (SI) motion is analyzed (left: red, right: green). Boxplots of amplitudes (SI) (b) and periods (c) over all breathing cycles of the 4DMRIs. SI displacements over time for MRI1–MRI5 (d–h). Selected motion patterns for 4DCT(MRI) generation are marked by gray shaded areas
FIGURE 4Example coronal and sagittal 4DCT(MRI) slices at different breathing phases of CT2(MRI1) (a–d) and CT11(MRI2) (e–h). For CT2(MR1) the reference end exhale (EE) phase and an end inhalation (EI) phase are shown. For CT11(MRI2) the deep‐inspiration breath‐hold (DIBH) reference and an EE phase are displayed. The clinical target volume (CTV) is contoured on each image. The white lines have been inserted for visual reference
FIGURE 5Overlay of end inhalation digitally reconstructed radiograph (DRR) from 4DCT (green) and 4DCT(CT) (pink) for CT1–CT6 (left) and relative change of the pixel values of the 4DCT(CT) DRR relative to the 4DCT DRR (right)
FIGURE 6Overlay of sagittal slice of 4DCT (green) and 4DCT(CT) (pink) in (a–f) and patched 4DCT (pink) in (g–l) for CT1–CT6. All slices show the end inhalation phase and the tumor is visible in all slices
FIGURE 7Dose distributions and dose differences for CT6 from 4D dose calculation on the original 4DCT (b), 4DCT(CT) (c), and patched 4DCT (d). The static dose distribution is shown in (a) and the chosen field directions are indicated with white arrows. Dose distributions and differences are shown as percentages of the prescribed dose and the same colormaps were used for all dose distributions and dose differences, respectively
For each of 4DCTs the 2%/2 mm gamma pass rates between the 4DCT and the patched 4DCT (p4DCT), the 4DCT, and the 4DCT(CT) as well as the p4DCT and the 4DCT(CT) are listed
| Gamma pass rate (%) |
| Mean dose healthy lung (%) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4DCT/p4DCT | 4DCT/4DCT(CT) | p4DCT/4DCT(CT) | Static | 4DCT | p4DCT | 4DCT(CT) | Static | 4DCT | p4DCT | 4DCT(CT) | |
| CT1 | 95.0 | 93.8 | 98.6 | 82.8 | 34.2 | 33.7 | 33.5 | 3.6 | 3.4 | 3.5 | 3.4 |
| CT2 | 92.9 | 90.8 | 97.9 | 97.5 | 39.0 | 38.3 | 40.1 | 5.3 | 5.7 | 5.7 | 5.6 |
| CT3 | 82.5 | 77.3 | 94.9 | 89.9 | 26.3 | 27.0 | 32.3 | 3.8 | 4.2 | 4.2 | 4.0 |
| CT4 | 97.8 | 97.2 | 99.2 | 91.9 | 36.6 | 37.2 | 46.4 | 1.9 | 1.9 | 1.9 | 1.9 |
| CT5 | 92.6 | 88.7 | 96.8 | 93.5 | 66.3 | 67.0 | 67.8 | 3.3 | 3.5 | 3.5 | 3.1 |
| CT6 | 98.9 | 96.8 | 97.9 | 92.6 | 66.2 | 66.5 | 64.7 | 12.0 | 12.0 | 12.0 | 11.6 |
| Average | 93.3 | 90.8 | 97.5 | 91.4 | 44.7 | 44.9 | 47.5 | 5.0 | 5.1 | 5.1 | 4.9 |
Note: V 95% and the mean dose to the surrounding healthy lung half were calculated for the static plan and the 4D dose calculations for the 4DCT, p4DCT, and 4DCT(CT).
Abbreviation: CTV, clinical target volume.